𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Resection of progressive or residual tumor after treatment with imatinib for advanced GI stromal tumors

✍ Scribed by P. Hohenberger; U. Schneider; D. Pink; K. Emmerich; C. Kettelhack; O. Roetschke; P. Reichardt

Book ID
110547638
Publisher
Springer
Year
2004
Tongue
English
Weight
144 KB
Volume
11
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Resection of residual disease in patient
Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib
✍ Sebastian Bauer; JΓΆrg Thomas Hartmann; Maike de Wit; Hauke Lang; Florian Grabell πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 723 KB

## Abstract Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Long‐term survival of patients with metastatic disease has only been observed in patients with completely resected disease. Recently, the tyrosine kinase inhibitor imatinib has b